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ABSTRACT 
Innovation is one of the pharmaceutical industry’s most defining characteristics. New medications can be crucial for maintaining the quality 
of human life, and may even affect its duration. The pressure to succeed is tremendous. Pharmaceutical innovation is hardly an orderly, predictable 
process. It follows a technology-push model dependent on a twisting route of scientific breakthroughs with uneven timing and hard to foresee outcomes. 
Drug innovation as a business process requires perception strategic, organizational, and managerial decisions. It is already enjoying intensive research 
coverage, giving rise to abundant but relatively dispersed knowledge of the mechanisms driving drug discovery and  development. This will be a 
comprehensive impression of the process of drug innovation from a business and academic perspective. the evolving organizational forms and models 
for collaboration, summarize significant empirical regularities, and highlight differences in market positions related to firms’ strategic orientation, 
innovation emphasis, attitudes to risk, and specialized resources. As a guide to future research, critical drivers and modes for drug innovation are 
systematized in a unifying framework of characteristics and process decisions. Because of its rich potential and high significance, research on drug 
innovation seems poised to gain increasing momentum in the years to come. 
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INTRODUCTION 
 As biology and technology become ever more closely 
intertwined, new opportunities are emerging to improve healthcare 
through the use of innovative digital technologies. We live in an age in 
which technology is moving at a rapid pace, creating new fields and 
disrupting existing models and processes [1]. From a career standpoint, 
staying abreast of new innovations in Pharma can be extremely 
beneficial, helping you to adapt to change, seize new opportunities and 
focus on developing the skills that you will need in the future.  New 
innovations in Pharma are proving to have great potential in 
pharmaceutical research and development of new drugs as well as 
improving patient outcomes and increasing patient access through 
reduced costs [2].  Five Innovations Pharma Sector Industry:                   
1. Precision Medicine 
2. mhealth Sensors 
3. Artificial Intelligence 
4. Nano robot  
5. 3D Printing 
Introduction: 
Precision medicine is an approach that integrates clinical and 
molecular information to understand the biological basis of disease. This 
information can be obtained by converting DNA into data through a 
process called genome sequencing. Researchers can use this data to 
identify specific gene abnormalities, or biomarkers, to understand  
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DOI:  
which types of patients a drug will be most effective for, and who is 
likely to experience severe side-effects. This can aid in the development 
of new targeted therapies and the repurposing of existing drugs [3]. 
Targeted therapies are tailored to the genetic makeup of individual 
patients so genomic testing is required to ascertain the most effective 
therapy before it is administered. This understanding of the relationship 
between a drug and an individual's genes enables doctors to 
administer the right drug for the right patient at the right dose, first time 
– leading to better outcomes and reduced adverse effects [4]. In the 
UK, GlaxoSmithKline, Roche, AstraZeneca, Biogen, AbbVie and others 
are reportedly working with Genomics England on their project 
to sequence 100,000 genomes from 70,000 NHS patients with rare 
diseases and cancer, both Roche and Pfizer have also agreed deals with 
23andMe to access their community of patients with Parkinson’s and 
Crohn’s disease respectively, to look for genetic clues to their causes [5]. 
Working: 
• Identify the gene in which disease. 
• Identify the protein associated with gene. 
• Understanding the proteins structure and function. 
• Replace the gene with another gene.  
 
Fig. 1: Precision medicine 
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Fig. 2: Precision medicine 
Applications:  
Get to optimal therapy more quickly: The use of diagnostic tests can 
help the health care provider to select a treatment option with the 
greatest probability of success at the outset, helping to reduce inefficient 
“trial and error” prescribing.  
Use drugs more safely: Screening tests can identify patients who have 
an elevated risk for an adverse reaction to specific medicines. Also, 
individuals with uncommon variants of drug metabolizing enzymes and 
transporters may need a different dose, or may not benefit sufficiently 
or at all from certain medicines [6]. 
Increase patient compliance: The failure of patients to adhere to 
prescribed treatment plans exacerbates their medical condition and 
increases medical costs resulting from no treatment. When a therapy 
proves more effective or has a more favorable safety profile for a 
patient, the patient is more likely to adhere to the treatment.  
Leverage “precision medicine” principles to increase the probability 
of success in R&D: Biopharmaceutical research and development 
focused on narrower, well-defined patient subpopulations has the 
potential to increase the speed of clinical trials and increase the 
probability of demonstrating clear clinical benefit.  
Reduce inefficiencies in health care: Optimal practice of personalized 
medicine can help reduce many of the inefficiencies in the current 
health care system. Awareness of genetic risk factors encourages 
preventive care and early diagnosis, prevention of advanced disease 
states, reduction of ineffective treatment, and avoidance of additional 
care resulting from adverse drug reactions. 
USES: 
1. Diabetes 
2. Arthritis 
3. Depression 
4. Cancer 
5. Schizophrenia 
Uses of precision medicine in cancer therapy: 
Drug responsiveness of patients also diverge, resulting in 
poor therapeutic outcomes. Alternatively, targeted cancer therapies, 
although quite successful initially, frequently fail due to development of 
drug resistance and adverse side effects. Precision medicine involves a 
multitude of techniques and research forces like Epigenetics, Proteomics 
and Metabolomics, and research itself will generate new tools and 
technology, which will benefit our scientific society as a whole. 
Furthermore, precision medicine preludes the era of patient-informed 
therapy [7]. Revelation of patient’s genome raises ethical issues of 
acknowledgement rights in compromise to psychological stress. It also 
raises political and legal issues regarding liabilities to clinical decision 
making. Implementations will also foster collaboration with the 
industrial and commercial sector, for example, pharmaceutical 
companies and medical device manufacturers that provide 
indispensable products and services. Lateral economic expansion, 
specifically, medical travel, is complimentary. Hence, the Precision 
Medicine Initiative collectively nurtures and coheres different social 
sectors on the path to success. In conclusion, the cancer precision 
medicine willleverage advances in biotechnologies, such as next 
generation sequencing, proteomics, transcriptome, epigenetics, 
pharmacology and bioinformatics, to identify precise causes for cancers 
and develop tailor-fit personalized therapies .As part of the Precision 
Medicine Initiative, this is an indispensable and near-term goal towards 
broader application on other diseases including diabetes, obesity, etc. 
Hence, the recent call for Precision Medicine Initiative rapidly went into 
spotlight throughout the world [8]. 
Precision medicine involves a multitude of technologies in 
order to gain success. The combination of genomics analysis and drug 
screening will yield unpredicted pharmacological outcome and reveal 
information for precise disease diagnosis and treatment [8]. 
Precision medicines in breast cancer: 
Breast cancer is the most common cancer diagnosed in 
women, and one in eight women living in the United States has a lifetime 
risk of developing the disease. Breast cancer is also one of the most 
studied solid tumors and has the potential for being manageable with a 
precision medicine approach [9]. 
 
 
Fig. 3: Precision Medicine for Personalized Cancer Therapy. 
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Fig. 4: Precision Medicine for Therapy. 
NANOROBOTICS: 
Introduction: 
Nanotechnology is the study, design, creation, synthesis, 
manipulation, and application of Materials, devices, and systems at the 
nanometer scale. The application of nanotechnology in the field of 
health care, drug delivery has come under great attention in recent 
times. Using nanotechnology, quicker and much cheaper treatments can 
be developed. Therefore nanotechnology can help save the lives of many 
people. Nanotechnology, when used with biology or medicine, is 
referred to as nano biotechnology. A nanometer is one-billionth of a 
meter, too small to be seen with a conventional lab microscope. It is at 
this size scale about 100 nanometers or less that biological molecules 
and structures inside living cells operate. Nanotechnology involves the 
creation and use of materials and devices at the level of molecules and 
atoms [9]. 
Nano robots in drug delivery system: 
Nanorobots are robots that carry out a very specific function 
and are just several nanometers wide. They can be used very effectively 
for drug delivery. Normally, drugs work through the entire body before 
they reach the disease affected area. Using nanotechnology, the drug can 
be targeted to a precise location which would make the drug much more 
effective and reduce the chances of possible side-effects. Medical nano 
devices would first be injected into a human body, and would then go to 
work in a specific organ or tissue mass. The doctor will monitor the 
progress, and make certain that the progress, and make certain that the 
Nano devices have gotten to the correct target treatment region. The 
doctor will also be able to scan a section of the body, and actually see the 
Nano devices congregated neatly around their target (a tumor mass, 
etc.) so that he or she can be sure that the procedure was successful [10]. 
Robotic design in drug delivery: 
Research in the design side of Nano robotics has determined 
information about their properties that will affect their use in drug 
delivery application. This has been accomplished by viewing the human 
body from a molecular standpoint, which provides a better 
understanding of what is required of Nano machines in that 
environment.  
Size and volume: 
Nano robot working in tissue could be as large as 50-100 
microns, whereas one in the bloodstream needs to be 500-3000 nm. 
Injection of a dose of 3 cubic cm would be acceptable for the human 
body, since it has an average blood volume of 5400 cubic cm. 
Acoustic power: 
Another area to address is how the nanorobots are powered 
in the body. Some suggest that power be supplied by glucose and oxygen 
already present in the body. Alternately, external Acoustic power could 
be supplied. Some believe that energy storage devices are a necessary 
Supplementary supply. This will be an important area to further 
research, as onboard volume on the robots is limited. Acoustic signals 
sent back and forth between the nanorobots and the external source 
could theoretically provide steady communication. Communication will 
be necessary at least between nanorobots to pass sensory and control 
data for ensuring correct operation and monitoring progress. It will 
most likely also be used to transmit information to a human patient and 
medical personnel. 
Surface: 
The immune system will react to the presence of these 
devices is also being investigated. Since the immune system will attack 
any foreign objects present, it is proposed that the nanorobots be made 
with smooth, flawless, diamond surfaces. Experimental studies show 
that diamond exteriors may be ideal, because less leukocyte activity and 
fibrinogen adsorption occurs with these chemically inert surfaces. 
Shape: 
Another aspect for consideration is the shape of the device. 
While biological nanorobots can move freely with respect to one 
another, mechanical components are supported by stiff housing. 
Flexibility would make it much easier for the device to enter the 
cytoplasm, affect micro hydrodynamic stability and more. 
Methods of navigation: 
Two methods of navigation are currently being considered: 
1) Positional: where the Nano robot knows its place in the body.  
2) Functional: where the nanorobot detects subtle variations in the 
environment to compare to a set of predefined conditions. 
A Fictitious Nano device: 
The device is designed to travel to a site where it releases a 
short-lived drug molecule that has been converted onboard from a 
stable precursor. It is becoming clear how biological molecules, 
especially proteins, might be combined with other materials to make 
individual components of a device. But, it is not obvious how the 
complete device, or even a simplified version of it, might be assembled 
and integrated into a functional whole. Such a Nano device would also 
have to fight thermal motion and local flow to maintain its bearings. A 
fictitious Nano device is as shown in “Fig. 5” [11]. 
It consists of following parts: 
1. Sensing device 2. Computing device  3. Shell 
 
Fig. 5: Nano device 
Mechanisms: 
1. Uptake 2. Catalysis 3. Release       4. Energy consumption.  
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Nano robot Locomotion: 
Assuming the nanorobots isn't tethered or designed to float 
passively through the bloodstream, it will need a means of propulsion to 
get around the body. Because it may have to travel against the flow of 
blood, the propulsion system has to be relatively strong for its size. 
Another important consideration is the safety of the patient the system 
able to move the nanorobots around without causing damage to the host 
[12]. 
  
 
              Fig. 6: Nano device                                                     Fig. 7: Nano robot tools will have to be small enough to  
     manipulate cells like RBC 
APPLICATIONS: 
Application in diabetes: 
Nanorobots are considered a new possibility for the health 
sector to improve medical instrumentation, diagnosis, and therapeutic 
treatments. Patients with diabetes must take small blood samples many 
times a day to control glucose levels. Such procedures are 
uncomfortable and extremely inconvenient. To avoid this kind of 
problem the level of sugar in the body can be observed via constant 
glucose monitoring using medical nanorobotics. This automatic 
information can help doctors, specialists and professionals from 
formulation field to provide a real-time health care, improving the 
patient's medication regimen. Medical nanorobot manufacturing should 
include embedded and integrated devices, which can comprise the 
parts: 1. Sensing 2. Actuation Data transmission   3. Remote control 
uploading 4. Coupling power supply subsystems addressing the basics 
to biomedical instrumentation [13]. 
A) Nanorobots role through physiological point of view: 
a) A multiplicity of blood-borne nanorobots should allow glucose 
monitoring not just at a permitting the physician to assemble a 
whole-body map of serum glucose concentrations. 
b) Examination of time series data from many locations allows 
precise measurement of the rate of change of glucose concentration 
in the blood that is passing through specific organs, tissues, specific 
vessels. 
c) Whole-body time series data collected while the patient performs 
at various activity levels (e.g., resting, postprandial) could have 
additional diagnostic value in assessing the course and extent of 
disease. 
B) Mechanism of Nanorobots in glucose monitoring: 
Glucose carried via the bloodstream is important to keep the 
human metabolism working Health fully, and its correct level is a key 
issue in the diagnosis and treatment of diabetes. The glycemic levels and 
parameters for an adult with diabetes should stay inside the pre-
established target range. Normally persons with diabetes must try to 
keep their blood glucose levels (BGLs) between 90 and 130 mg/dL [14]. 
Hours after eating: 
The nanorobots has embedded Nano bioelectronics as 
prototyping methodology for hardware architecture integration 
whether the nanorobots is invisible or visible for the immune reactions, 
it encounters no interference when detecting glucose levels in the blood 
stream. Because of its biocompatibility the nanorobot is not attacked 
inside the body by the white blood cells, making it invisible to the 
immune system. For glucose monitoring the nanorobotuses an 
embedded chemo sensor that involves the modulation of human 
sodium/glucose co- transporter type protein glucosensor activity. Using 
an embedded chemical biosensor the nanorobots can determine if the 
individual needs to drug release or not. 
Amelioration of heart attack: 
Nanorobots can also be used to prevent heart-attacks. Heart-
attacks are caused by fat deposits blocking the blood vessels. 
Nanorobots can be made for removing these fat deposits. The 
nanorobots removing the yellow which is fat deposits on the inner side 
of blood vessels. From this hypothesis, such technology will help for 
delivery of drugs like lipid lowering substances such as lovastatin, 
simvastatin etc. These drug molecules will enter with nanorobots and 
give delivery at the site of action. 
Tissue reconstruction: 
Nanoparticles with nanorobots can be designed with a 
structure very similar to the bone structure. An ultrasound is performed 
on existing bone structures and then bone like nanoparticles are created 
using the results of the ultrasound. The bone-like nanoparticles are 
inserted into the body with the help of fins of nanorobots. When they 
arrive at the fractured bone, they assemble themselves to form an 
ordered structure which later becomes part of the bone. These 
applications will helpful in case of bone fractures, arthritic conditions 
etc [15]. 
Nerve regeneration: 
Another key application for nanorobots is the treatment of 
injured nerves. Samuel Stupp and John Kessler at Northwestern 
University in Chicago have made tiny rod like nano-fibers which were 
incorporated in nanorobots called amphiphiles. They are capped with 
amino acids and are known to spur the growth of neurons and prevent 
scar tissue formation. Experiments have shown that rat and mice with 
spinal injuries recovered when treated with these devices. 
 
Fig. 8: Working of miniature camera inside blood vessels 
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Working of miniature camera inside blood vessels which are 
nearby to the nerves. Such camera gives pictorial view which in 
communication with communicating device and guides for further 
treatment [16]. 
Nanorobots in cancer therapy: 
In Cancer Therapy, targeting and localized delivery are the 
key challenges. To overcome the Shortcomings of conventional methods, 
we have to selectively attack the cancer cells, while saving the non-
malignant tissue from excessive burdens of drug toxicity. Theoretically, 
the proposed nanorobots should do the: 
1. Nano-Sensors to sense the presence of malignant cells in body. 
2. Nanocarriers to carry the combined NanoSensor-NanoDrug 
Encapsulate to vicinity of tissues. 
3. Nano drug delivery particles to encapsulate drugs to be delivered 
at specific cancerous tissue sites and controlled drug-delivery at 
specific sites. 
4. A Nano-Computer/Brain to integrate the above activities in a 
complex In-Vivo environment. 
Functional components of nanorobots in cancer therapy which 
entailed as below: 
A) Locomotion unit: 
The primary purpose of NanoCarrier would be capability of 
automated navigation in the human body, to the vicinity of the 
organ/tissue where carcinogenic tissue issuspected. Understanding the 
motion of lower animal forms, such as bacterial flagella motion, can help 
to design and fabricate bio-inspired robots able to navigate in 
tortuous,slippery and difficult to access cavities of the human body. In 
general, such an approach is termed as Biomimetic. 
Navigation technique: 
a) Positional navigation: The first strategy is positional navigation, in 
which the nanorobot knows its position inside the human body to 
micron accuracy at all times in some clinic centered or body centered 
coordinate grid system. This method requires some onboard 
computation, at least a basic set of sensors (e.g., acoustic), and probably 
also a good clock (Nanochronometry). However, if the target 
coordinates are poorly specified, the system might fail or lead to 
positional errors [17]. 
b) Functional navigation: The second strategy is functional navigation, 
in which Nano devices seek to detect subtle variations in their 
environment, comparing diverse sensor readings with the profile of the 
target tissue or cell and congregating wherever this very precisely 
defined set of preconditions exists. These preconditions may be thermal, 
acoustic or barostatic, or immunochemical, mechanical or topological, or 
even genetic. 
B) Nanosensors: 
A specific bio molecular interaction between target and probe 
molecules alters the intermolecular interactions within a self-assembled 
monolayer on one side of a cantilever beam. This can produce a 
sufficiently large force to bend the cantilever beam and generate motion. 
The origin of this Nano mechanical motion lays in the interplay between 
changes in configurationally entropy and the intermolecular energetics.  
C) Drug encapsulation and drug delivery: 
Nano-enabled controlled drug delivery technology involves 
multidisciplinary scientific approach, and is very much essential in an 
effective Nano-enabled cancer therapy. These delivery systems offer 
numerous advantages compared to conventional dosage forms, which 
include improved efficacy, reduced toxicity and improved patient 
compliance and convenience. Here drug is attached to a carrier molecule 
such as a synthetic polymer, antibody, hormone or liposome [18]. As the 
absorption and distribution of the drug in such a system depend on the 
properties of the macromolecular carrier, parameters such as site 
specificity, protection from degradation and minimization of side effects 
can be altered by modifying the properties of the carrier. Nano shell 
combination with nanodevice in cancer therapy Nano device like as 
nanorobots if have been used in case of drug delivery along with Nano 
shell containing polymer and drug will give the better drug load at 
targeted site. It have developed a platform for Nano scale drug delivery 
called the Nano shell-dielectric metal (gold coated silica) Nano spheres 
whose optical resonance is a function of the relative size of the 
constituent layers. These nano shells, embedded in a drug containing 
tumor targeted hydrogel polymer, and then injected into the body, 
accumulate near tumor cells. When heated with an infrared laser, the 
Nano shells selectively absorb a specific Infrared frequency, melting the 
polymer and releasing the drug payload at a specific site [19]. 
Nanorobots in kidney diseases: Kidney stones can be intensely painful 
the larger the stone the more difficult it is to pass. Doctors break up 
large kidney stones using ultrasonic frequencies, but it's not always 
effective. Nanorobots could break up kidney stones using a small laser. 
 
Fig. 9: Break up of kidney stones using a small laser 
Treating arteriosclerosis: Arteriosclerosis refers to a condition where 
plaque builds along the walls of arteries. Nanorobots could conceivably 
treat the condition by cutting away the plaque, which would then enter 
the bloodstream. 
 
Fig. 10: Treating arteriosclerosis 
Gout: 
In Gout, the kidneys lose the ability to remove waste from the 
breakdown of fats from the bloodstream. This waste sometimes 
crystallizes at points near joints like the knees and ankles. People who 
suffer from gout experience intense pain at these joints. Nanorobots 
could break up the crystalline structures at the joints, providing relief 
from the symptoms, though it wouldn’t be able to reverse the condition 
[20]. 
ARTIFICIAL INTELLIGENCY: 
Introduction:  
Artificial Intelligence is advancing technology in healthcare. 
By providing rich and relevant information to patients and HCPs with 
on-demand medical and clinical confidence, AI can greatly advance 
healthcare professional (HCP) and patient communications [21]. Artificial 
intelligence is available today for HCP and patient use, and can even be 
tailored to personality profiles to support patients beyond disease. 
Artificial intelligence is well known for advancing precision medicine 
and more recently, genomic analytics. In Japan, doctors used IBM 
Watson to diagnose a patient with a rare form of leukemia [22]. Use of AI 
allowed them to diagnose the oncology patient and identify a lifesaving 
therapy much faster than if they had used traditional methods by 
manually examining the patient’s genetic data. The researchers had to 
supply genetic data from the patient and then Watson crosschecked it 
with database of previous patients. Watson was then able to detect gene 
mutations that are unique to a particular type of leukemia [23]. 
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Applications: 
 Artificial intelligence helps the HLI team identify patterns in huge 
data sets of genetic information and medical records [24]. 
 As is common with technologic advances, AI is replacing jobs that 
previously required humans with computers. It is being applied to 
repetitive types of jobs or actions in healthcare.  
 It is also helping to speed up telemedicine. It is able to improve 
online consultations by recognizing patient history and symptoms 
more quickly, and recommending the best course of action [25]. 
 Cataloguing of medical knowledge. 
 Produces new tools to support medical decision-making, training 
and research. 
 Integrates activities in medical, computer, cognitive and other 
sciences [26]. 
D-PRINTING (3DP): 
Introduction: 
 It is the art and science of printing in a new dimension using 
3D printers to transform 3D computer aided designs (CAD) into life-
changing products. 
3D printing technology: It is a process of making three dimensional 
solid objects from a digital file. The creation of a 3D printed object is 
achieved using additive processes. In an additive process an object is 
created by laying down successive layers of material until the entire 
object is created. Each of these layers can be seen as a thinly sliced 
horizontal cross-section of the eventual object. It acquired an impact as 
standard tool in the automotive, aerospace, and consumer goods 
industries. More recently, 3D printing has gained interest in 
pharmaceutical manufacturing, with FDA‘s approval of a 3D-printed 
drug product in August 2015 [27]. 
History: 
Early Additive Manufacturing (AM) equipment and materials 
were developed in the 1981. In1981, Hideo Kodama of Nagoya 
Municipal Industrial Research Institute invented two AM fabricating 
methods of a three-dimensional plastic model with photo-hardening 
polymer, where the UV exposure area is controlled by a mask pattern or 
the scanning fiber transmitter. July 16, 1984 Alain Le Méhauté , Olivier 
de Witte and Jean Claude André filed their patent for the stereo 
lithography process [28]. The application of French inventors was 
abandoned by the French General Electric Company (now Alcatel-
Alsthom) and CILAS (The Laser Consortium).[28] Then in 1984, Chuck 
Hull of 3D Systems Corporation developed a prototype system based on 
a process known as Stereo lithography, in which layers are added by 
curing photopolymers with ultraviolet light lasers. Hull defined the 
process as a "system for generating three-dimensional objects by 
creating a cross-sectional pattern of the object to be formed". His 
contribution is the design of the STL (Stereo Lithography) file format 
widely accepted by 3D printing software as well as the digital slicing and 
infill strategies common to many processes today [29]. 
Working: 
The different types of 3D printers each employ a different 
technology that processes different materials in different ways. A 
process polymer resin materials and again utilize a light/laser to solidify 
the resin in ultra-thin layers. Jetting of fine droplets is another 3D 
printing process, reminiscent of 2D inkjet printing, but with superior 
materials to ink and a binder to fix the layers. Perhaps the most common 
and easily recognized process is deposition, and this is the process 
employed by the majority of entry-level 3D printers [30]. There are many 
steps prior to pressing print and more once the part comes off the 
printer-these are often overlooked. Apart from the realities of designing 
for 3D printing, which can be demanding, file preparation and 
conversion can also prove time-consuming and complicated, 
particularly for parts that demand intricate supports during the build 
process [31]. There are continual updates and upgrades of software for 
these Layers by layer the printer will create the predetermined shape 
functions and the situation is improving. Furthermore, once of the 
printer, many parts will need to undergo finishing operations. Support 
removal is an obvious one for processes that demand support, but 
others include sanding, lacquer, paint or other types of traditional 
finishing touches, which all typically need to be done by hand and 
require skill and/or time and patience [32]. 
Advantages: 
1. Ability to customize products. 
2. Rapid production of   prototypes. 
3. Low cost of production. 
4. Increased employment opportunities. 
5. No storage cost. 
6. Improves the safety, efficacy, and accessibility of medicine. 
Disadvantages: 
1. Intellectual property issues. 
2. Unchecked production of dangerous items. 
3. Limitations of size. 
4. Limitations of raw material. 
5. Cost of printers is high. 
 
 
Fig. 11: 3D Printing 
Working of 3D printing technology: 
It starts with making a virtual design of the object to be 
created. This virtual design is made in a CAD (Computer Aided Design) 
file using a 3D modeling program or with the use of a 3D scanner. 3D 
designs are typically converted to the STL file format, which describes 
the external surface of a 3D model. 3D printing programs slice these 
surfaces into distinct printable layers and transfers layer by-layer 
instructions digitally to the printer. After printing, products may require 
drying, polishing or other post-processing steps [33]. Standard 
Terminology for Additive Manufacturing Technologies is as follows: 
1. Material Jetting: It differs substantially from binder jetting, and can 
be challenging to implement. Advantage of material jetting over binder 
jetting and other methods is resolution; inkjet droplets are about 100 
μm in diameter and layer thicknesses for material jetting are smaller 
than the droplet diameter. Commonly jetted materials include molten 
polymers and waxes, UV-curable resins, solutions, suspensions, and 
complex multicomponent fluids. 
2. Binder Jetting: The primary 3D printing technology used for 
pharmaceutical production is inkjet deposition on powder beds. Inkjet 
printers spray formulations of drugs or binders in small droplets at 
precise speeds, motions, and sizes onto a powder bed. The 
liquidformulation inside the printer may contain a binder only, and the 
powder bed may contain the active ingredient (API) with additional 
excipients. Alternatively APIs can be jettedonto powder beds as 
solutions or nan particulate suspensions. 
3. Material Extrusion: The material is extruded from robotically-
actuated nozzles. Unlike binder jetting, which requires a powder bed, 
extrusion methods can print on any substrate. Common type of 
extrusion printing is fused filament fabrication (FFF), also known by the 
trademarked name: fused deposition modeling™ (FDM®) [34]. 
4. Powder Bed Fusion: It involves sintering (partial surface melting and 
congealing) or binding of high-melting-point particles with a low-
melting-point binder.  
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5. Photopolymerization: Also known as stereo lithography.involves 
exposing liquid resins to ultraviolet or other high-energy light source to 
induce polymerization reactions.  
6. Directed Energy Deposition: Is a process where raw materials are 
melted by a focused energy source (ex: laser or electron beam) as they 
are being deposited. The method allows the use of powders or other raw 
materials that cannot be extruded [35]. 
7. Sheet Lamination: Automated laser-cutting and sheet-by-sheet 
assembly of products. This process is quick and inexpensive but also 
low-resolution and more wasteful than most printing methods.  
Future of 3d printing: 
Bioprinting is based on bio-ink, which is made of living cell 
structures. When a particular digital model is input, specific living tissue 
is printed and built up layer by cell layer. Bioprinting research is being 
developed to print different types of tissue, while 3D inkjet printing is 
being used to develop advanced medical devices and tools [36]. There is a 
growing trend towards personalized and customized medicines.  
This technology may transform the pharmacy practice by 
allowing medications to be truly individualized and tailored to a patient 
[37]. Moreover the technology enables preparation of dosage forms with 
accurate deposition of materials, greater spatial control and geometric 
flexibility. There is a great hope of 3D bioprinting in producing 
reproducible biological constructs for producing structures for studies 
into implantation, regenerative medicine and automated assays for high 
throughput in vitro drug and toxicity studies in lab developed tissues 
[38]. 
 
Fig. 12: SPRITAM   it is an epilepsy drug 1st 3D printed drug 
approved by FDA 
Use of 3d printing: [39] 
1. Tissues with blood vessels 
2. Low–Cost Prosthetic Parts 
3. Drugs 
4. Tailor-made sensors 
5. Medical Models 
6. Bone 
7. Heart Valve 
8. Ear cartilage 
9. Medical equipment 
10. Cranium Replacement 
11. Synthetic skin 
12. Organs 
mHEALTH: 
Introduction: 
Pharma research institutes are already beginning to take 
advantage of mHealth technology to conduct clinical research. 
Smartphones with powerful processors and advanced sensors that can 
track movement, take measurements and record information are highly 
useful in post-market studies and allow people to participate in studies 
more easily. Mobile phone or smartphone becomes the most important 
communication device in people lives.. For now, mobile phones can use 
a variety of wireless communication techniques (GSM,Wi-Fi, Bluetooth 
and others). It allows to integrate mobile phones into existing 
healthcare services and also to create new services and applications in 
this area. Practical medicine and healthcare services supported by 
mobile devices are called mHealth solutions. This field is growing fast 
recently .mHealth applications are delivered via online stores, such as 
App Store, Google Play, Overstore and others that increase availability of 
mobile healthcare solutions. Another important factor, which 
determines applicability of mobile phones for healthcare purposes, is 
that a modern mobile phone is equipped with powerful embedded 
sensors, such as microphone, accelerometer, camera and others. There 
are surveys of mobile phone sensing applications, e.g., in variety of 
domains including healthcare, social networks, safety, environmental 
monitoring and transportation. Researchers notice that these sensors 
open new horizons for mobile healthcare applications, but they did not 
review a lot of such applications, so the main use cases of mobile phone 
sensors in mHealth were not disclosed. In this article we survey Health 
applications, which use embedded sensors and also demonstrate the 
main use cases for such sensors in these applications. The remainder of 
the paper is organized as follows. In Sec. II we present most popular 
sensors, which are used in modern mobile phones and discuss their 
general applications. In Sec. III we review existing mHealth applications, 
which use embedded sensors of mobile devices and discuss the main 
advantages of internal sensors usage.  
 
 
Fig. 13: m health activity 
Mobile phone sensors: 
All embedded sensors of a mobile phone can be subdivided 
into two categories. The first one includes environment sensors and the 
other contains position and orientation sensors. Environment sensors 
are used to measure different properties of the mobile phone 
environment. Microphone and camera are examples of the first sensor 
group. Such sensors as accelerometer, digital compass, gyroscope and 
GPS form position and orientation sensors group. They are used to 
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determine orientation of the mobile phone in space and also device 
location. Camera is another very popular mobile phone sensor and its 
general task is photo taking and often video recording. The use of 
camera sensor can be extended to interact with real world objects, in 
this case a local analysis of photos or video stream is needed. For 
example, such analysis was proposed to read 2D codes. The other 
environment sensors are a light sensor and a proximity sensor. The light 
sensor measures intensity of ambient light and can be used to adjust 
brightness of the screen. The proximity sensor detects presence of 
nearby objects. When the user holds the phone close to his or her ear to 
answer the call, the screen is blocked to prevent accidental touch. 
Accelerometers and magnetometers are the sensors, which purpose is 
to determine a device orientation in space. Accelerometer measures 
acceleration across two or three directions. The resulted data are used 
to change screen orientation .Accelerometers can also provide a new 
way of interaction with the phone, e.g., in motion-sensitive mini-games 
to control a game process. Whereas the accelerometer in the mobile 
device allows measuring the linear acceleration of the device, a 
gyroscope helps to directly determine the orientation relative to the 
earth magnetic field. Generally, these sensors are used for navigation 
but also can be applied in new techniques to interact with mobile device 
using properly shaped permanent magnet. 
MOBILE PHONE SENSORS IN HEALTHCARE APPLICATIONS: 
Applications: 
A. Microphone sensor: 
There are several use cases of microphone in mHealth. In 
healthcare this sensor is obviously used for communication. It offers an 
effective means of bringing healthcare services to citizens that is 
extremely topical for developing countries. One of the key applications 
for mHealth in such countries are: 
- Communication and training for healthcare workers; 
-Disease and epidemic outbreak tracking; 
-Diagnostic and treatment support. 
In some cases the microphone can also be used to assess 
patient feels, e.g., it was shown for patients with the myotonic 
syndrome. Myotonia is a disorder characterized by slow relaxation of 
muscles after contraction, which may cause a difficulty to move. 
According the proposed method, within 8 weeks patients had to call to 
the data collection service and to talk about their health. Automated 
voice response system classified symptoms into the four categories: 
muscle stiffness, weakness, pain and tiredness. Thus the system allows 
reducing the number of the doctor visits because assessment can be 
done automatically and allows monitoring such patients without 
hospitalization [40]. 
B. Camera sensor: 
The mobile phone camera sensor can be used to provide 
useful information about a patient images and videos that applies in 
such applications as remote doctor consultation. The more significant 
example of using mobile device camera in healthcare services is the 
teledermatology, where the patient skin images are used by the doctor 
to make a diagnosis. Teledermatology solutions exist in the market of 
healthcare services. For instance, one of them is provided by ClickMedix. 
The solution consists of the following parts: a mobile application, a data 
collection center and professionals in dermatology. To use this service a 
patient should be registered in the system. After registration the user is 
instructed on how to take photos of their skin correctly. Then, using the 
mobile application, the patient takes photos of his/her skin and sends 
them to the data collection server. The doctor gets access to these data 
and prescribes a treatment according to the analysis [41]. The service 
provider suggests using such a remote consultation when a patient 
cannot have recourse to qualified specialists for one of the following 
reasons: 
1) Lack of access: patients cannot easily reach doctors; 
2) Lack of funds: patients cannot afford the high cost of healthcare; 
3) Lack of medical resources: most countries face the severe 
shortages of trained healthcare professionals, especially medical 
specialists, to perform an adequate diagnosis and quality treatment in 
rural areas. Another type of medical consultation involving mobile 
phone camera includes, for example, a remote doctor advising, which 
is used in Taiwan and China for teleconsultation and diagnostics of 
soft tissue injuries. Such applications decrease overall number of 
medical center visits by patient and eventually lead to the 
improvement of the healthcare. Several new applications in the 
cardiology field of mobile phone camera were proposed recently. 
There are two different ways to use phone camera in this field. The 
first one is to detect heart rate through human skin color analysis. It 
tracks color changes in the light that passes through a finger [42]. 
C. Accelerometer sensor and geolocation facilities: 
The main application of accelerometers for healthcare 
purposes is to track a person’s physical activity level. It is important as it 
allows reducing the risk of having many chronic diseases. There are 
specially designed accelerometer-based devices that measure activity 
level as a number of steps performed by the person. Such devices are 
called pedometers. To detect steps they capture readings from 
accelerometers and recognize the step pattern. Some pedometers can 
also calculate approximate number of burned calories. Embedded 
accelerometer of a mobile phone allows implementing the same 
functionality as pedometers provide. The main advantage of such a 
solution is that there is no need to have an additional sensing device. 
Several mobile pedometer applications are available for different 
popular mobile platforms. Although pedometer-like systems can be very 
useful for physical activity tracking, they are usually focused only on 
step counting and do not consider other daily activities, such as walking 
or running. For more accurate physical activity monitoring a system has 
to be able to detect different types of activity, including walking, 
running, bicycle riding, car driving and others. To recognize different 
activity patterns some studies use only a single accelerometer. For 
example, in the data were collected from tri-axial accelerometer worn 
on person’s waist. The authors use Bayesian classification for activity 
recognition. As a result, approximately80% accuracy has been achieved 
using such activity classification technique. Similar studies have good 
accuracy in activity classification, but require additional equipment or 
use devices made only for research purposes. The requirement for 
additional devices makessuch systems inconvenient for a practical use 
[43]. 
 
Fig. 14: m health activity equipped in mobile phones 
Recently mobile phones equipped with different embedded 
sensors have been used inseveral studies to collect data for activity 
classification. To create classification model some of these approaches 
use data from several internal modules, such as microphone, GPS and 
camera. The other approaches use only accelerometer data and aimed 
toachieve phone orientation independence along with high accuracy of 
activity classification. Accelerometer is also the central information 
source in human fall detection studies. In these studies fall detection is 
based on recognition of specific patters in accelerometer data. When the 
fall is detected, the system can send an emergency signal to the 
monitoring system. Such applications are very useful for elderly people 
monitoring. Unfortunately, the existing solutions for fall detection, for 
example Brick house, allows to detect falls only in limited environments, 
e.g., at home. Such systems are too expensive because they use special 
devices. They use accelerometer data from mobile phone built-in 
accelerometer and do not need any external devices. Such systems give 
an advantage over the other solutions to detect falls everywhere. 
Moreover, vast coverage of mobile phone communication services 
allows supplementing emergency call information with exact patient 
location determined using GPS module. Another useful application of 
mobile phone accelerometers has been proposed in projectm-Physicto 
provides rehabilitation service [44]. A patient using the system does not 
need to come to the rehabilitation center several times, but can perform 
rehabilitation exercises at home. To estimate training accuracy mobile 
phone with accelerometer is used. The first stage of the system usage is 
the system learning when patient perform exercise under specialist 
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supervision. The second stage is a personal rehabilitation when the 
patients perform his/her rehabilitation exercises at home. During these 
exercises the systems captures the physical activity and classify it into 
four types: correct exercise, wrong exercise, exercise exceeds the 
maximum time, exercise does not exceed the minimum time. The system 
helps the patient to assess how accurately they perform exercises 
themselves. The experiments demonstrated that using this system the 
user constantly improves accuracy of personal rehabilitation exercises. 
Used with the help of:  1. Smartphones: (Samsung gear) 2.Fit ness band: 
(fit bit, jawbone) [45]. 
Summary: 
 New innovations in Pharma can be extremely beneficial, helping 
you to adapt to change, seize new opportunities and focus on 
developing the skills that you will need in the future.   
 Precision medicine is an approach that integrates clinical and 
molecular information to understand the biological basis of 
disease, hence it is useful in treatment of diseases like 
Parkinsonism, cancer etc. 
 Using nanotechnology, the drug can be targeted to a precise 
location which would make the drug much more effective and 
reduce the chances of possible side-effects. 
 Artificial Intelligence is a rapidly advancing technology in 
healthcare, providing rich and relevant information to patients and 
HCPs with on-demand medical and clinical confidence, it can 
greatly advance healthcare professional (HCP) and patient 
communications. 
 3D printing or additive manufacturing is a process of making three 
dimensional solid objects from a digital file. 
 There is an abundance of issues and themes that merit 
considerable research attention in the field of pharmaceutical 
innovation. This compilation will be a useful platform for many 
enthusiastic researchers to join in and contribute to the 
burgeoning stream of studies related to the discovery and 
development of efficacious novel drugs. 
CONCLUSION 
The world is becoming an increasingly more compact place, 
presenting ample opportunities for dispersed innovation and expedient 
collaboration. Continuous innovation is one of the pharmaceutical 
industry’s most defining characteristics. New medications can be crucial 
for maintaining the quality of human life, and may even affect its 
duration. This is particularly evident to global pharmaceutical 
companies whose subsidiaries and research centers are already spread 
around the world. Future research could also look into the implications 
of using fundamental knowledge generated by nonprofit research 
institutions on the secrecy and proprietary rights demanded by private 
firms. The signaling value on industry participants of organizational 
changes enacted through partnerships such as licensing, co-marketing 
agreements, alliances, mergers, or acquisitions could constitute another 
fecund area of study. More research is needed to identify the 
environmental, structural, and strategic determinants that can affect 
drug innovation outcomes. Pharmaceutical innovation is hardly an 
orderly, predictable process. Drug innovation as a business process 
requires savvy strategic, organizational, and managerial decisions. It is 
already enjoying intensive research coverage, giving rise to abundant 
but relatively dispersed knowledge of the mechanisms driving drug 
discovery and development.  
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